How did ABEO's revenue and expenses trend in Q4 2024?

Abeona Therapeutics Inc. (ABEO) reported a net loss of $30.3 million for the third quarter of 2024, with research and development expenses totaling $8.9 million. No additional data was provided regarding revenue for this quarter.